In a release, the Company noted that it received net proceeds of approximately $47.5 million after deducting placement agent fees and other offering expenses. All of the securities were offered pursuant to an effective shelf registration statement. Proceeds from the transaction will be used for general corporate purposes. After the offering, the company has 48,707,303 shares issued and outstanding. A shelf registration statement relating to the shares of common stock and warrants issued in the offering (and the shares of common stock issuable upon exercise of the warrants) has been filed with the Securities and Exchange Commission (the "SEC") and has been declared effective. A prospectus supplement relating to the offering was filed with the SEC. Copies of the prospectus supplement and accompanying prospectus may be obtained directly from the Company. Rodman & Renshaw, a subsidiary of Rodman & Renshaw Capital Group, Inc., acted as the exclusive placement agent for the transaction. ((Comments on this story may be sent to health@closeupmedia.com)) For full details on Spectrum Pharm Inc (SPPI) click here. Spectrum Pharm Inc (SPPI) has Short Term PowerRatings of 3. Details on Spectrum Pharm Inc (SPPI) Short Term PowerRatings is available at This Link.
![]()
Email Print Archives Feedback Email Article Link
Close X
Related News [SPPI]
UPCOMING EVENTS
Learn new strategies, how to trade in this market, and the stocks you should be focusing on each day. Join us for our free 20 minute tele-seminars during the week.
Thursday December 3 12:30 PM
* Attendance is strictly limited and are filled on a first-come, first-served basis.
The TradingMarkets Directory
Stocks
Options
Forex
E-mini/Futures
How to Trade
Tools
PowerRatings
Blogs
|